PMV Pharmaceuticals Inc (PMVP)
1.615
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 16:00
1.62
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals Cash from Operations (TTM): -55.66M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -55.66M |
September 30, 2023 | -58.90M |
June 30, 2023 | -60.00M |
March 31, 2023 | -60.77M |
December 31, 2022 | -63.76M |
September 30, 2022 | -60.46M |
June 30, 2022 | -56.10M |
Date | Value |
---|---|
March 31, 2022 | -51.66M |
December 31, 2021 | -46.57M |
September 30, 2021 | -44.86M |
June 30, 2021 | -39.85M |
March 31, 2021 | -37.50M |
December 31, 2020 | -32.74M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-63.76M
Minimum
Dec 2022
-32.74M
Maximum
Dec 2020
-51.45M
Average
-55.66M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
Exelixis Inc | 333.32M |
Geron Corp | -167.74M |
Verastem Inc | -86.46M |
Karyopharm Therapeutics Inc | -92.72M |
Kura Oncology Inc | -124.82M |